Ulrich Laufs to Apolipoprotein B-100
This is a "connection" page, showing publications Ulrich Laufs has written about Apolipoprotein B-100.
Connection Strength
0.201
-
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study. Vascul Pharmacol. 2019 05; 116:8-15.
Score: 0.201
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.